Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab And/or Nivolumab in Hodgkin Lymphoma.
Edgar Gonzalez-Kozlova,Hsin-Hui Huang,Opeyemi A. Jagede,Kevin Tuballes,Diane M. Del Valle,Geoffrey Kelly,Manishkumar Patel,Hui Xie,Jocelyn Harris,Kimberly Argueta,Kai Nie,Vanessa Barcessat,Radim Moravec,Jennifer Altreuter,Dzifa Y. Duose,Brad S. Kahl, Stephen M. Ansell,Joyce Yu,Ethan Cerami,James R. Lindsay,Ignacio I. Wistuba,Seunghee Kim-Schulze,Catherine S. Diefenbach,Sacha Gnjatic CANCER RESEARCH COMMUNICATIONS（2024）
AI 理解论文
溯源树
样例
